[ASTRO] QoQ Annualized Quarter Result on 31-Jan-2023 [#4]

Stock
[ASTRO] ASTRO MALAYSIA HOLDINGS BERHAD
Announcement Date
27-Mar-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2023
Quarter
31-Jan-2023 [#4]
Profit Trend
QoQ- -4.9%
YoY- -43.79%
Quarter Report
Latest QR
Upcoming QR
ASTRO's Result
ASTRO's Financial Summary
View:
Show?
Annualized Quarter Result
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Revenue 3,363,825 3,521,892 3,564,504 3,800,065 3,745,857 3,766,418 3,848,356 -8.55%
PBT 10,609 100,512 82,540 288,941 327,674 508,254 507,740 -92.36%
Tax -32,827 -34,888 -30,196 -78,453 -69,714 -127,284 -124,652 -58.81%
NP -22,218 65,624 52,344 210,488 257,960 380,970 383,088 -
-
NP to SH -10,006 79,092 63,580 259,038 272,380 396,968 400,072 -
-
Tax Rate 309.43% 34.71% 36.58% 27.15% 21.28% 25.04% 24.55% -
Total Cost 3,386,043 3,456,268 3,512,160 3,589,577 3,487,897 3,385,448 3,465,268 -1.52%
-
Net Worth 1,081,903 1,133,654 1,111,211 1,071,059 1,131,547 1,168,049 1,176,392 -5.41%
Dividend
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Div 17,396 26,073 52,145 156,435 208,580 234,652 260,725 -83.46%
Div Payout % 0.00% 32.97% 82.01% 60.39% 76.58% 59.11% 65.17% -
Equity
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Net Worth 1,081,903 1,133,654 1,111,211 1,071,059 1,131,547 1,168,049 1,176,392 -5.41%
NOSH 5,219,023 5,214,506 5,214,506 5,214,506 5,214,506 5,214,506 5,214,506 0.05%
Ratio Analysis
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
NP Margin -0.66% 1.86% 1.47% 5.54% 6.89% 10.11% 9.95% -
ROE -0.92% 6.98% 5.72% 24.19% 24.07% 33.99% 34.01% -
Per Share
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
RPS 64.45 67.54 68.36 72.87 71.84 72.23 73.80 -8.61%
EPS -0.20 1.52 1.20 4.98 5.23 7.62 7.68 -
DPS 0.33 0.50 1.00 3.00 4.00 4.50 5.00 -83.58%
NAPS 0.2073 0.2174 0.2131 0.2054 0.217 0.224 0.2256 -5.46%
Adjusted Per Share Value based on latest NOSH - 5,214,506
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
RPS 64.45 67.48 68.30 72.81 71.77 72.17 73.74 -8.56%
EPS -0.20 1.52 1.22 4.96 5.22 7.61 7.67 -
DPS 0.33 0.50 1.00 3.00 4.00 4.50 5.00 -83.58%
NAPS 0.2073 0.2172 0.2129 0.2052 0.2168 0.2238 0.2254 -5.41%
Price Multiplier on Financial Quarter End Date
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Date 31/10/23 31/07/23 28/04/23 31/01/23 31/10/22 29/07/22 29/04/22 -
Price 0.415 0.535 0.695 0.615 0.675 0.895 1.00 -
P/RPS 0.64 0.79 1.02 0.84 0.94 1.24 1.35 -39.11%
P/EPS -216.45 35.27 57.00 12.38 12.92 11.76 13.03 -
EY -0.46 2.84 1.75 8.08 7.74 8.51 7.67 -
DY 0.80 0.93 1.44 4.88 5.93 5.03 5.00 -70.42%
P/NAPS 2.00 2.46 3.26 2.99 3.11 4.00 4.43 -41.06%
Price Multiplier on Announcement Date
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Date 14/12/23 25/09/23 19/06/23 27/03/23 15/12/22 26/09/22 21/06/22 -
Price 0.365 0.51 0.66 0.66 0.71 0.83 0.94 -
P/RPS 0.57 0.76 0.97 0.91 0.99 1.15 1.27 -41.29%
P/EPS -190.37 33.62 54.13 13.29 13.59 10.90 12.25 -
EY -0.53 2.97 1.85 7.53 7.36 9.17 8.16 -
DY 0.91 0.98 1.52 4.55 5.63 5.42 5.32 -69.08%
P/NAPS 1.76 2.35 3.10 3.21 3.27 3.71 4.17 -43.64%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment